Relapsing-Remitting Multiple Sclerosis (MS) Market Trends, Demand, Share, Major Player, Competitive Outlook Forecast to 2020-2027
Relapsing-Remitting Multiple Sclerosis (MS) Market Research Report: By Treatment (Immunomodulating Drugs, Nrf2 Activators, Interferons, Others), By Route of Administration (Oral, Intravenous) and By End-User (Hospitals, Clinics, Others) – Forecast to 2027
Market Highlights
According to MRFR analysis, the global relapsing-remitting (MS) market is expected to register a CAGR of 3.1% during the forecast period of 2019 to 2025 and held a value of USD 4,976 million in 2018.
Relapsing-remitting MS is characterized by attacks of new or increasing neurologic symptoms. These attacks are also called relapses or exacerbations and are followed by periods of partial or complete recovery. Approximately 85% of people with MS are initially diagnosed with relapsing-remitting MS.
The growth of the global relapsing-remitting MS market is boosted by various factors such as rising research in the multiple sclerosis treatment fields, and increasing innovations by significant players. However, the stringent regulations and high cost of drugs are likely to curb the growth of the global relapsing-remitting MS market.
Several market players currently dominate the global relapsing-remitting MS market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in March 2017, the US Food and Drug Administration (FDA) approved Genentech’s Ocrevus (ocrelizumab) for the treatment of adult patients with relapsing forms of multiple sclerosis and primary progressive multiple sclerosis (PPMS).
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8377
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the upcoming research activities by key players. The relapsing-remitting MS market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European relapsing-remitting MS market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The relapsing-remitting MS market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing pool of patient population suffering from relapsing-remitting MS, the market in Asia-Pacific is expected to be the fastest-growing. The relapsing-remitting MS market in the Middle East & Africa has been divided into the Middle East and Africa.
Segmentation
The global relapsing-remitting MS market has been segmented based on treatment, route of administration, and end user.
The market, based on treatment, has been divided into immunomodulating drugs, Nrf2 activators, interferons, and others. The immunomodulating drugs segment is likely to be the largest during the review period due to the growing advantages of this drug type in comparison to others. The Nrf2 activators segment is predicted to be the fastest-growing due to the increasing awareness and research in the market.
The global relapsing-remitting MS market has been segmented, based on the route of administration, into oral and intravenous. The oral segment is expected to hold the majority share of the market owing to the increasing efficiency rates of this mechanism. The intravenous segment is expected to be the fastest-growing due to the increased awareness about this route of administration.
The end users of the market are hospitals, clinics, and others. The hospitals segment is expected to hold the largest share of the market due to the increasing number of hospitals. The clinics segment is expected to be the fastest growing owing to the increased preference of medical professionals.
Key Players
Some of the key players in the global relapsing-remitting MS market are Glenmark Pharmaceuticals (India), Eisai Co., Ltd (Japan), Biogen (US), Merck KGaA (US), Sanofi Genzyme (US), Novartis AG (Switzerland), and Teva Pharmaceutical Industries Ltd (Israel).
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/relapsing-remitting-multiple-sclerosis-market-8377
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
I had my TL a little more than a year ago when my third child was born via c-section. I was not told ANYTHING about the possible side effects of having this procedure. Since then I have experienced heavy bleeding lasting sometimes 3 weeks out of the month, weight gain, severe mood swings. Severe cramping, changes to my libido, severe depression accompanied by suicidal thoughts, headaches, migraines, many new symptoms & older issues are now exacerbated. The father of two of my children doesn't want me anymore. I've become too much of a pain in the ass I guess. We don't talk. We don't sleep in the same bed. I think he might really think I am crazy... & maybe I am. I feel crazy a lot of the time.
ReplyDeleteI'm unpredictable. I feel so angry about the whole thing & now what was once a mild fear of doctors has exploded into full on white coat syndrome that causes me to have a panic attack/hypertensive emergency (severe increase in blood pressure) whenever I have to deal with them. I'm not sure what to do... I fear the next time I have to see a doctor I'll have a stroke or a heart attack from the stress & anxiety of it... what do I do? I take my time and keep searching on internet looking for natural healing that how I came across Dr Itua herbal center website and I was so excited when Dr Itua told me to calm down that he will help me with his natural remedy I put my hope on him so I purchase his herbal medicines which was shipped to my address I used it as prescribed guess what? I'm totally healed my cramp pain is gone completely I also used his Anti Bacteria herbal medicines it's works for me very well I want anyone with health problem to contact Dr Itua herbal center for any kind diseases remedies such as Parkinson, Herpes, ALS, MS, Diabetes, Hepatitis, Hiv/Aids,Cancers, Men & Women Infertility, I got his email address drituaherbalcenter@gmail.com he has any kind of herbal remedies for women & men also for our babes. I really miss my Hunni...he's a fantastic father & a good man. He doesn't deserve this. I feel like an empty shell of who I used to be...